ADZA Adeza Biomedical (MM)

Adeza (NASDAQ: ADZA) today announced that Mark Fischer-Colbrie, chief financial officer, will make an investment community presentation at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on Wednesday, November 9, at 11:15 a.m. Eastern Time (8:15 a.m. Pacific Time). The conference is being held at the Palace Hotel in New York City. A live audio webcast and slide presentation will be available via the Internet by visiting the "Investors" section of the company's Web site at www.adeza.com. An archived presentation will be available on the Web site for 14 days. About Adeza Adeza designs, manufactures and markets innovative products for women's health. Adeza's initial focus is on reproductive healthcare, using its proprietary technologies to predict preterm birth and assess infertility. Adeza's principal product is a patented diagnostic test, FullTerm(R), The Fetal Fibronectin Test, which utilizes a single-use, disposable cassette and is analyzed on Adeza's patented TLiIQ(R) System. This product is approved by the U.S. Food and Drug Administration (FDA) for use in assessing the risk of preterm birth. Adeza also markets and sells the E-tegrity(R) Test, an infertility-related test to assess receptivity of the uterus to embryo implantation in women with unexplained infertility. More information is available at www.adeza.com. Adeza cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Adeza that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Adeza's business including, without limitation, statements about the expansion of the indications for its products. All forward-looking statements are qualified in their entirety by this cautionary statement and Adeza undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.